These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6196290)

  • 21. [The monamine metabolites in the CSF of the patients with spinocerebellar degeneration and motor neuron disease (author's transl)].
    Yamamoto M
    Rinsho Shinkeigaku; 1980 Jul; 20(7):503-9. PubMed ID: 6161732
    [No Abstract]   [Full Text] [Related]  

  • 22. CSF HVA and 5-HIAA.
    Wood JH
    Neurology; 1979 Jun; 29(6):910-12. PubMed ID: 572023
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cerebrospinal fluid amine metabolites and L-dopa in vegetative state patients (author's transl)].
    Inagawa T; Ishikawa S; Uozumi T
    No Shinkei Geka; 1978 Mar; 6(3):235-43. PubMed ID: 643153
    [No Abstract]   [Full Text] [Related]  

  • 24. Encephalopathy associated with bismuth salt ingestion and brain monoamines.
    Passouant P; Billiard M; Besset A; Renaud B
    Int J Neurol; 1979; 13(1-4):199-204. PubMed ID: 95615
    [No Abstract]   [Full Text] [Related]  

  • 25. Homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid of a child with familial dysautonomia.
    Andersson H; Hagne I; Roos BE
    Acta Paediatr Scand; 1973 Jan; 62(1):46-8. PubMed ID: 4691255
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in the patients with epilepsy (author's transl)].
    Nagao T; Fujimoto A; Ohshimo T; Yamamoto M; Kugoh T; Akiyama K; Otsuki S
    No To Shinkei; 1979 Dec; 31(12):1225-31. PubMed ID: 93481
    [No Abstract]   [Full Text] [Related]  

  • 27. Acidic metabolites of dopamine and serotonin in cerebrospinal fluid.
    Sourkes TL
    Adv Neurol; 1974; 5():271-3. PubMed ID: 4440576
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of baclofen on cerebrospinal-fluid levels of 5-hydroxyindoleacetic acid and homovanillic acid.
    Walinder J; Wallin L; Carlsson A
    N Engl J Med; 1977 Feb; 296(8):452-3. PubMed ID: 834217
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of ethanol ingestion on cyclic AMP, homovanillic acid and 5-hydroxyindoleacetic acid in human cerebrospinal fluid.
    Orenberg EK; Zarone VP; Renson JF; Barchas JD
    Life Sci; 1976 Dec; 19(11):1669-72. PubMed ID: 187886
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison between fluorometric and mass fragmentographic determinations of homovanillic acid and 5-hydroxyindoleacetic acid in human cerebrospinal fluid.
    Sjöquist B; Johansson B
    J Neurochem; 1978 Sep; 31(3):621-5. PubMed ID: 576110
    [No Abstract]   [Full Text] [Related]  

  • 31. Homovanillic acid and 5-hydroxyindole-acetic acid in the csf of patients after a severe head injury. I. Lumbar csf concentration in chronic brain post-traumatic syndromes.
    Bareggi SR; Porta M; Selenati A; Assael BM; Calderini G; Collice M; Rossanda M; Morselli PL
    Eur Neurol; 1975; 13(6):528-44. PubMed ID: 1193100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of clozapine on the excretion of 3-methoxy-4-hydroxy-phenylglycol, homovanillic acid and 5-hydroxy-indole acetic acid in urine and cerebrospinal fluid].
    Ackenheil M; Beckmann H; Hoffmann G; Markianos E; Nyström I; Raese J
    Arzneimittelforschung; 1974 Jul; 24(7):984-7. PubMed ID: 4408052
    [No Abstract]   [Full Text] [Related]  

  • 33. [HVA and 5-HIAA in the cerebrospinal fluid in extrapyramidal and cerebrellar syndromes. Preliminary data].
    Carrieri P; Mandarini A; Campanella G
    Acta Neurol (Napoli); 1975; 30(5):449-54. PubMed ID: 132845
    [No Abstract]   [Full Text] [Related]  

  • 34. [Total sleep deprivation in normal humans. Changes in anxiety, depression and aggressiveness and HVA and 5-HIAA levels in the lumbar cerebrospinal fluid].
    Genco S; Puca FM; Livrea P; Specchio LM; Lamberti P; Di Reda L; Papagno G
    Boll Soc Ital Biol Sper; 1976 Jun; 52(11):794-9. PubMed ID: 1016631
    [No Abstract]   [Full Text] [Related]  

  • 35. Homovanilic acid in Huntington's disease and Sydenham's chorea.
    Cunha L; Oliveira CR; Diniz M; Amaral R; Conçalves AF; Pio-Abreu J
    J Neurol Neurosurg Psychiatry; 1981 Mar; 44(3):258-61. PubMed ID: 6453208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE; Foxx JL; Butler IJ
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of non-fluctuating progressive dystonia: a neuropharmacological approach.
    Willemse J; van Nieuwenhuizen O; Gooskens RH; Westenberg HG
    Neuropediatrics; 1984 Oct; 15(4):208-10. PubMed ID: 6208504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical investigations in Parkinsonism. A study of the metabolites of the biogenic amines in the lumbar CSF.
    Pullar IA; Dowson JH; Ahmed R; Chow R; Gillingham FJ
    Confin Neurol; 1972; 34(2):143-8. PubMed ID: 4666057
    [No Abstract]   [Full Text] [Related]  

  • 39. The influence of the lying and sitting positions on the gradients of 5-HIAA and HVA in lumbar cerebrospinal fluid.
    Gateless D; Stanley M; Träskman-Bendz L; Gilroy J
    Biol Psychiatry; 1984 Nov; 19(11):1585-9. PubMed ID: 6083808
    [No Abstract]   [Full Text] [Related]  

  • 40. Monoamine metabolites in successive samples of spinal fluid. A comparison between healthy volunteers and patients with multiple sclerosis.
    Andersen O; Johansson BB; Svennerholm L
    Acta Neurol Scand; 1981 Apr; 63(4):247-54. PubMed ID: 6163303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.